Mark Soave

Years Active: 2019-2022
Publications (10 Years): 5

University of Nottingham

University of Nottingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nottingham Nov 01 2016

United Kingdom

Research Fellow :: Cell Signalling Research Group

Education History

University of Nottingham Oct 01 2013 - Sep 30 2016

United Kingdom

PHD

University of Durham Oct 01 2008 - Jun 30 2011

United Kingdom

BSC

Publications

Joëlle Goulding, Sarah J Mistry, Mark Soave, Jeanette Woolard, Stephen J Briddon, Carl W White, Barrie Kellam, Stephen J Hill
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRISPR/Cas9 genome-edited HEK293T cells at low expression levels. Pharmacology research & perspectives 9 (3) (2022)
Mark Soave, Leigh A Stoddart, Carl W White, Laura E Kilpatrick, Joëlle Goulding, Stephen J Briddon, Stephen J Hill
Detection of genome-edited and endogenously expressed G protein-coupled receptors. The FEBS journal 288 (8) (2021)
Ines Liebscher, Orkun Cevheroğlu, Cheng-Chih Hsiao, André F Maia, Hannes Schihada, Nicole Scholz, Mark Soave, Katja Spiess, Katarina Trajković, Mickey Kosloff, Simone Prömel
A guide to adhesion GPCR research. The FEBS journal (2021)
Mark Soave, Stephen J Briddon, Stephen J Hill, Leigh A Stoddart
Fluorescent ligands: Bringing light to emerging GPCR paradigms. British journal of pharmacology 177 (5) (2020)
Samantha L Cooper, Mark Soave, Manuela Jörg, Peter J Scammells, Jeanette Woolard, Stephen J Hill
Probe dependence of allosteric enhancers on the binding affinity of adenosine A1 -receptor agonists at rat and human A1 -receptors measured using NanoBRET. British journal of pharmacology 176 (7) (2019)

Mark Soave.css-eqlu8i{font-size:small;padding-left:4px;}